Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.
David C MullerTricia L LaroseAllison HodgeFlorence GuidaArnulf LanghammerKjell GrankvistKlaus MeyerQiuyin CaiAlan A ArslanAnne Zeleniuch-JacquotteDemetrius AlbanesGraham G GilesHoward D SessoI-Min LeeJ Michael GazianoJian-Min YuanJudith Hoffman BoltonJulie E BuringKala VisvanathanLoic Le MarchandMark P PurdueNeil E CaporasoØivind MidttunPer M UelandRoss L PrenticeStephanie J WeinsteinVictoria L StevensWei ZhengWilliam J BlotXiao-Ou ShuXuehong ZhangYong-Bing XiangWoon-Puay KohKristian HveemCynthia A ThomsonMary PettingerGunnar EngströmHans BrunnströmRoger L MilneMeir J StampferJiali HanMikael JohanssonPaul BrennanGianluca SeveriMattias JohanssonPublished in: BMJ (Clinical research ed.) (2019)
Former and current smokers with higher circulating hsCRP concentrations had a higher risk of lung cancer overall. Circulating hsCRP concentration was not associated with the risk of lung adenocarcinoma. Circulating hsCRP concentration could be a prediagnostic marker of lung cancer rather than a causal risk factor.
Keyphrases